The subjects exhibiting a serum ACE2 level ≤1.06 ng/ml indicated significantly higher rates of postoperative MI, arrhythmia and reduced cardiac output, as well as greater in-hospital mortality following CABG, compared with those exhibiting a serum ACE2 level >1.06 ng/ml (Table IV). The gene discussed is ACE2; the disease is Arrhythmia.